Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2024-03-20
2024-04-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* What is the best hypoxia exposure to improve reaction time, anticipation, attention and memory tasks?
* Which hypoxia exposure causes the greatest detriments in cognitive function?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intermittent Normobaric Hypoxia on Executive Functions
NCT07027410
Effect of High Altitude Exposure, Acclimatization and Re-exposure on Sustained Attention in Lowlanders
NCT02738307
Cognitive Stimulation in Older With Mild Cognitive Impairment
NCT03831061
Measuring Cognitive Enhancement During Hyperbaric Oxygen Treatments
NCT04358796
Effects of Cognitive Stimulation in Older People With Mild Cognitive Impairment
NCT04663256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
11% FiO2
Hypoxic exposure: fraction of oxygen inspired (FiO2) = 11% (\~5100 m, \~16735 ft)
Hypoxia
Hypoxic exposure: FiO2 = 11% Hypoxic exposure: FiO2 = 13% Hypoxic exposure: FiO2 = 15% Hypoxic exposure / placebo: FiO2 = 21%
13% FiO2
Hypoxic exposure: fraction of oxygen inspired (FiO2) = 13% (\~3800 m, \~12470 ft)
Hypoxia
Hypoxic exposure: FiO2 = 11% Hypoxic exposure: FiO2 = 13% Hypoxic exposure: FiO2 = 15% Hypoxic exposure / placebo: FiO2 = 21%
15% FiO2
Hypoxic exposure: fraction of oxygen inspired (FiO2) = 15% (\~2750 m, \~9000 ft)
Hypoxia
Hypoxic exposure: FiO2 = 11% Hypoxic exposure: FiO2 = 13% Hypoxic exposure: FiO2 = 15% Hypoxic exposure / placebo: FiO2 = 21%
PLA / 21% FiO2
Hypoxic exposure / placebo condition: fraction of oxygen inspired (FiO2) = 21% (sea level)
Hypoxia
Hypoxic exposure: FiO2 = 11% Hypoxic exposure: FiO2 = 13% Hypoxic exposure: FiO2 = 15% Hypoxic exposure / placebo: FiO2 = 21%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hypoxia
Hypoxic exposure: FiO2 = 11% Hypoxic exposure: FiO2 = 13% Hypoxic exposure: FiO2 = 15% Hypoxic exposure / placebo: FiO2 = 21%
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-smokers
* Individuals without serious and undiagnosed health problems
Exclusion Criteria
* Residing at an altitude of more than 1300 m
* Having been exposed to an altitude of more than 900 m in the last 8 months
* Having performed a study with hypoxia in the last 8 months
* Suffering from any of the following diseases/pathologies: diabetes, sleep apnoea, dyslexia, colour blindness, blurred vision, respiratory and/or neuromuscular diseases.
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Castilla-La Mancha
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Performance and Sport Rehabilitation Laobratory. University of Castilla-La Mancha
Toledo, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYP_MR_2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.